Aurobindo Reprimanded By SEBI Over US FDA Warning Disclosure
‘Very Limited And Restricted Information’ Revealed By Indian Firm Deemed ‘Insufficient’
• By David Wallace
The Securities and Exchange Board of India says Aurobindo’s disclosures were not sufficient • Source: Shutterstock 
